Charles River Laboratories
Joseph LaPlume is an experienced executive in the life sciences sector, known for serving as the Corporate Executive Vice President of Corporate Development and Strategy at Charles River Laboratories from January 2011 to March 2019, leading global corporate strategic growth through mergers and acquisitions, technology licensing, and joint ventures. Prior to this role, LaPlume held various positions including Corporate Vice President of Corporate Development at GTECH Corporation and Senior Counsel at Goulston & Storrs. Additionally, LaPlume worked as a lawyer at Mintz Levin earlier in the career. Educational qualifications include an M.B.A. from the Questrom School of Business at Boston University and a J.D. from the Boston University School of Law.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
16 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.